Skip to content

Neutrophil Oxidative Burst in Early and Late Onset Pediatric Inflammatory Bowel Disease

Neutrophil Oxidative Burst in Early and Late Onset Pediatric Inflammatory Bowel Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06162936
Enrollment
150
Registered
2023-12-08
Start date
2023-11-01
Completion date
2025-02-28
Last updated
2023-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Granulomatous Disease

Keywords

inflammatory bowel disease, chronic granulomatous disease, inborn errors of immunity

Brief summary

ABSTRACT Introduction Residual or absent oxidase function in peripheral neutrophils may point to an inborn defect of neutrophil function - chronic granulomatous disease (CGD) - whereas low to normal oxidative burst capacity has been linked to variants in various members of the NADPH-complex. Aims To assess the clinical value of routinely measuring oxidative burst activity of granulocytes in pediatric patients diagnosed with very early onset IBD (VEO-IBD) and late onset IBD. Objectives To investigate possible correlations between neutrophil function and IBD disease activity and to inquire the presence of genetic variants in those with low to absent oxidative burst. To identify the rate of monogenic VEO-IBD in our cohort. Materials and Methods The proposal constitutes a collaborative effort among Romanian pediatric tertiary care centers to examine the value of assessing neutrophil function in all pediatric IBD patients. Children aged \<18 years diagnosed with Crohn's disease, ulcerative colitis or IBD-undetermined and age-matched healthy controls are recruited. A DHR flow cytometry assay is performed in included subjects and controls. Reduced or absent burst activity will lead to genetic testing in search of overt immunodeficiency or susceptibility variants. All VEO-IBD patients will have an immunological work-up in search of a primary immunodeficiency. Expected Results We anticipate to include a number of 150 pediatric patients with IBD over 12 months from the three pediatric gastroenterology units in Bucharest, Romania. We expect to identify an overall diminished neutrophil function in IBD patients versus controls and possible variants in the NADPH-complex genes.

Interventions

DIAGNOSTIC_TESTPhagoburst

The main objective is to perform oxidative burst activity in pediatric patients with a definitive diagnosis of IBD and compare them with healthy controls.

DIAGNOSTIC_TESTLymphocytes subsets

To determine lymphocytes subsets in patients with suspicion of IEI

DIAGNOSTIC_TESTGenetic testing

Perform targeted genetic testing in those with reduced to absent oxidative activity in search of PIDs and susceptibility variants

Sponsors

Marie Curie Emergency Children's Hospital, Bucharest
CollaboratorUNKNOWN
Victor Gomoiu Children's Hospital, Bucharest
CollaboratorUNKNOWN
National Institute for Mother and Child Health Alessandrescu Rusescu
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

Subjects: 1. age under 18 years; 2. confirmed diagnosis of IBD fulfilling standard diagnosis criteria (clinical, radiological, endoscopical, histological features) 3. parental/guardian consent for study enrollment Controls: Healthy age-gender matched controls

Exclusion criteria

1. IBD associated to an already defined monogenic defect 2. Diagnosis of IBD uncertain 3. HIV/TB positive

Design outcomes

Primary

MeasureTime frameDescription
Oxidative burst activity in IBD patients12 monthsPerform oxidative burst activity in pediatric patients with a definitive diagnosis of IBD and compare them with healthy controls.
Genetic testing in patients with suspicion of IEI12 monthsPerform targeted genetic testing in those with reduced to absent oxidative activity in search of PIDs and susceptibility variants

Secondary

MeasureTime frameDescription
Role of burst activity in disease phenotype12 monthsFind correlations between burst activity and disease activity

Countries

Romania

Contacts

Primary ContactAlexis Virgil Cochino, MD, PhD
alexis_virgil@yahoo.com+40723193648

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026